🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in India / NCT06814236
Starting soon Observational

Patients Gender Influence on Communication of Anaesthesia Risk

NCT06814236 · tracked via the Priya Life Science India tracker
Sponsor
Sir Ganga Ram Hospital
Phase
Observational
Started
2027-12
Last updated
2026-04-22

Condition(s) studied

Anaesthesia Complication

Investigational drug(s) / intervention(s)

Three-Stage Informed Consent Conversation Model for Anaesthesia Risk profiling

Three-Stage Informed Consent Conversation Model for Anaesthesia Risk profiling: Stage 1 Pre-information queries Do you know about the risks involved in Anaesthesia? If yes, where did you get information about the risks involved with Anaesthesia?? Which of these do you already know of and what concerns you most? Why are you concerned more about that particular risk factor? Stage 2 Informing Risks The probability or chances of supposed anaesthesia risks could be: Probable risk Possible risk Remote risk We have the following risk management strategy in place for your reassurance and safety: Employing ERAS protocol The surgery you are going to undergo, also may have its own set of risks Stage 3 Post-information Informing Risks In view of the above conversation we had, do you have other point of concern or query on what we have talked about.

Study summary

In Anaesthesia Practice, an Informed consent involves discussing the risks and benefits involved with a certain procedure and its alternatives. Though it is intended to promote patient autonomy and enhance decision-making, the risk profiling, detailing and discussing; generally walks one-way, from the anaesthesiologist to patient/party. This monologue-leaned communication is neither free flowing nor the patients are allowed to 'speak-up-first' on their concerns or queries. Several gaps can be identified including reluctance on the part of the anaesthesiologist to engage the patients in decision making or not upholding the patient preferences; or patient lacking sufficient knowledge to make an informed choice. Therefore, for risk communication, the very context has to be tailored to patient's individual needs.

There is no available study till date which has tried to address as how the communication between patient and the anaesthesiologist is influenced by the 'gender' of the patient concerned. This situates a need to understand how the 'gender' of a patient can influence communication during an Informed consent conversation on anaesthesia risk(s).

The study will explore to decipher if difference(s) in patient's gender influence their perceptions and understanding of anesthesia-related risks, and if the difference will influence the future lines of communication involving either of the gender. This prospective study will be based on conversation model based interview designed to assess the nuances of gender- based differences in risk perception and information exchange during pre-anaesthetic consultations.

Eligibility

Sex
ALL
Min age
20 Years
Max age
60 Years
Healthy volunteers
No
Inclusion Criteria: * Male and Female patients * Posted for short-2-moderate duration surgery * Willing to participate * Education \> Bachelors degree * ASA -I \& II physical grade Exclusion Criteria: * Patients posted for major surgery * Patients in for emergency surgery * ASA III-IV physical grade. * Patients refusing recording of the interview * Those looking to their family members to decide upon whether to participate in study • Patients agreeing to recording of the interview but refusing the recorded interview to be evaluated

Primary outcome measure(s)

Trial sites (2)

FacilityCityRegionStatus
Sir Ganga Ram Hospital New Delhi National Capital Territory of Delhi
Sir Ganga Ram Hospital New Delhi National Capital Territory of Delhi

More Sir Ganga Ram Hospital trials in India

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06814236 on ClinicalTrials.gov ↗ ← All trials in India